Abstract: Four-Week Inhalation Toxicity Study of 2,2-Dichloro-1,1,1-trifluoroethane (HCFC-123) in Guinea Pigs: Isamu KABE, et al. Department of Preventive Medicine and Public Health, School of Medicine, Keio University-Groups of eight male Hartley guinea pigs were exposed to 30, 100 or 300 ppm 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123) by inhalation for 6 hours a day for 4 wk. All the animals were sacrificed 48 h postexposure.
Guinea pigs exposed to 300 ppm HCFC-123 had significantly lower body weight and the weight gain than controls, but there was no significant difference and no tendency in absolute and relative organ weight. ICDH, ALT and AST, which were the most sensitive indicators of halothane-induced liver injury, did not differ significantly between exposed groups and controls. In the 100 ppm group, a few vacuolar fatty changes in the portal area (zone I) were identified. In the 300 ppm group, severe fatty degeneration was observed in the portal and intermediate areas, partly centrilobule, and the incidence increased significantly compared to the controls.
On the other hand, there was no histopathological change in the control or 30 ppm groups. No increase in any of the liver peroxisomal enzymes (AOX, PT, catalase) was seen in male guinea pigs exposed to HCFC-123. The activity of hepatic ALDH was significantly decreased in the 300 ppm exposed group, suggesting that HCFC-123 or its metabolite inhibited ALDH activity. In conclusion, inhalation exposure to 100 ppm or more of HCFC-123 for 4 wk produced nonfatal liver change in guinea pigs, namely hepatic fatty changes predominantly in the portal area (zone I) without any increase in AST, ALT or ICDH. The no-observed-adverse-effect level (NOAEL) of HCFC-1 23 for four wk in guinea pigs may be 30 ppm. Peroxisome proliferation, which may result in hepatocellular tumor induction, was not observed in guinea pigs exposed to HCFC-123. (J Occup Health 2001; 43: 314-320) 2,2-Dichloro 1, 1, 1 -trifluoroethane (HCFC-123, CAS No.306-83-2) is considered as a replacement for ozone depleting chlorofluorocarbons (CFCs), which are very stable in the atmosphere and may cause adverse effects in humans such as skin cancer 1-3'. HCFC-123 has been used as a foam-blowing agent, a refrigerant and a solvent in cleaning jobs. It is a colorless ether-odor liquid with a boiling point of 27.6°C at 1 torr, and its ozone deletion potential is 0.02. In 2000, 300 tons of HCFC 123 was shipped to Japan according to the statistics of the Japan Fluorocarbon Manufacturers Association. The Programme for Alternative Fluorocarbon Toxicity Testing (PAFT) has performed extensive toxicological evaluations including a 2-yr bioassay in rats for CFC substitutes (http:/ /www.afeas.org/paft/hcfc-123.html, last updated October 11, 1996). For HCFC-123, increases in the incidence of benign adenomas and in hepatic 113-oxidation were observed in chronic inhalation studies in 300-5,000 ppm (GC-8A, Shimazu) at 30-min intervals"'. The behavior and external appearance of the guinea pigs were observed every day. The body weight was measured before and after exposure every week. Twenty four h after the end of the final exposure, food was removed, and 48 h later, blood was collected from the inferior vena cava under anesthesia with i.p. injection of sodium pentobarbital. Their liver, kidneys, pancreas and testes were promptly removed and weighed. Liver tissues used for immunoblot analysis were frozen on dry ice immediately, and the rest were then fixed in 10% neutral buffered formalin, embedded in paraffin, sectioned and stained with hemotoxylin-eosin for light microscopic evaluation. They were also stained for fatty assessment with a solution of Sudan 7B and oil red 0 for visualization of neutral fatty acid, and examined microscopically. Histopathological findings were assessed by a pathologist.
Serum biochemical and hematological examinations
Serum biochemical indices examined were ICDH, aspartate aminotransferase (AST), alanine aminotransferase (ALT), y-glutamytransferase (),GTP), alkaline phosphatase (ALP), total bilirubin, direct bilirubin, indirect bilirubin, lactic dehydrogenase (LDH), LDH isozymes (LDH1, LDH2, LDH3, LDH4, LDH5), total cholesterol, triglyceride, blood urea nitrogen (BUN), creatinine and fasting blood glucose (FBG), which were measured by the standard clinical chemistry method (Hitachi 7450).
Hematological parameters included erythrocyte count (RBC), hemoglobin (Hb) and the total and differential counts of leukocytes (WBC, Stab, Seg, Lymph, Mono) measured by means of an automatic hemocytometry (Sysmex XE2 100).
Analysis of J3-oxidation enzymes and ALDH
The frozen liver sections were kept at 80°C until analysis. Liver extracts were subjected to 10% SDS polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. After blocking with 3% skim milk, the membranes were incubated with the primary antibody followed by alkaline phosphatase-conjugated goat anti-rabbit IgG (Jackson, West Grove). The primary polyclonal antibodies were prepared with purified acyl CoA oxidase (AOX)'"', peroxisomal thiolase (PT)'5' and catalase16', respectively. The signals obtained by immunoblot analysis were quantified by scanning densitometry and the mean of the values from the guinea pigs in the control group were assigned the value 1.0.
Total aldehyde dehydrogenase (ALDH) activity in the supernatant from liver centrifuged at 700 g was examined by measuring the rate of nicotinamide adenine dinucleotide (NADH) formation with acetaldehyde as a substrate. a single exposure in guinea pigs resulted in centrilobular vacuolar (fatty) change, multifocal random degeneration and necrosis of the liver with increase in serum AST, ALT and ICDH at 1,000 ppm or more'' It was therefore considered that HCFC-123 is hepatotoxic, and the no-observed-adverse-effect level (NOAEL) for four wk exposure to HCFC 123 in guinea pigs would be 30 ppm.
In a subchronic inhalation study with rats, Rusch et al. reported that histopathological findings were minimal and only induction of peroxisomal activity was seen at 300 ppm HCFC-123 for 90 d. There was no death or even marked signs of toxicity with 4-wk inhalation at 20,000 ppm". They therefore concluded that HCFC-123 had low inhalation toxicity. Moreover, the 2-yr inhalation toxicity of HCFC-123 was also low in rats at concentrations of 300-5,000 ppm''. PAFT therefore concluded that the inhalation toxicity of HCFC-123 is relatively low though an increased incidence of benign, but not life-threatening, tumors was observed in rats`-". These observations in rats are different from those in guinea pigs and in human subjects.
Reasons for such discrepancy may be explained by the species difference in the metabolic pathway of HCFC 123. The chemical structure of HCFC-123 is very similar to that of halothane (1-bromo-l-chloro-2,2,2 trifluoroethane), a well-known hepatotoxic chemical. In guinea pigs, halothane was mainly metabolized through the oxidative pathway by CYP 2E1, and formed reactive trifluoroacetylchloride that reacted with water to form trifluoroacetic acid (TFA) and trifluoroacetyl-protein adducts19 201. In rats, on the other hand, pretreatment with the P450 inducer, e.g. phenobarbital or hypoxia, was necessary to reproduce halothane toxicity in the liver, which means that reductive dehalogenation is the main pathway under normal conditions in rats21 2222'. The main metabolic pathway of halothane in humans is also the oxidative one with CYP 2E1, as in guinea pigs; a guinea pig model could therefore be more sensitive and more appropriate than a rat model to evaluate halothane hepatotoxicity in humans" 20 '-3 24'. It has been observed that HCFC-123 was also dehalogenated mainly in the oxidative pathway similar to halothane" '-9 26'. Higher TFA concentrations in urine have been detected among workers repeatedly exposed to HCFC-1239 11 13', and trifluoroacetyl-adducted proteins in the liver and serum CYP 2E1 autoantibodies have also been identified among workers repeatedly exposed to HCFC-123 and HCFC 1249'. Trifluoroacetyl-adducted proteins may cause immune hepatitis through neo-antigen formation. As both the structure and biotransformation of HCFC-123 is similar to those of halothane, a guinea pig should be a better model for evaluating HCFC-123-induced hepatotoxicity in humans. On the other hand, the toxicological evaluation of HCFC-123 in PAFT has been mainly performed in rats. Malley et al. reported hepatic beta-oxidation activity was higher in rats exposed to HCFC-123 at 300, 1,000 and 5,000 ppm (male) and 1,000 and 5,000 ppm (female) for 1 yr, but compound-related differences in the rate of hepatic cell proliferation were not observed at any concentrations'. In this study in guinea pigs, no induction of liver peroxisomal enzymes was found in any exposed group. Non-genotoxic hepatocarcinogenesis due to peroxisome proliferators has been well established in rodents, but this response largely depends on the species, i.e. humans and guinea pigs are relatively insensitive27 28)
.
Various experiments indicated that induction of ~3 oxidation with hepatic peroxisome proliferators was weak in guinea pigs and in humans compared to that in rats and mice29 30'. In this study, significant reduction of hepatic ALDH activity in the 300 ppm group may partly explain such low response to the peroxisome proliferator because a similar phenomenon was observed with trichloroethylene31).
The mechanism of peroxisome proliferation has been investigated, and might be mediated by the peroxisome proliferator activated receptor (X (PPAR)32). Inhibition of hepatic ALDH activity causes the metabolic production of TFA, which may be an obstacle to the induction of PPARa. Hepatocellular tumor induction caused by HCFC-123 therefore may not be relevant in guinea pigs or in humans. It has been suggested that PPARa expression in humans is lower than that in rodents, but it is sufficient to mediate such beneficial effects as hypolipidemic and hypoglycemic effects27• 33). We observed that the blood glucose level decreased in the 300 ppm group even though triglyceride and cholesterol levels were not affected in this experiment. As for the lack of induction of PPARa in the 300 ppm group, hepatic fatty changes may not result from the presence of PPARa but from the toxic effects of HCFC-123.
Male guinea pigs exposed to 300 ppm had significantly lower body weight and lower body weight gains than controls, and significantly decreased glucose. Previous studies reported that rats exposed to more than 300 ppm not only had lower body weight and lower gains but also decreased serum cholesterol and glucose', 5). The effect on body weight may be related to the compound-related disturbance in lipid and carbohydrate metabolism leading to hepatic fatty changes.
In conclusion, inhalation exposure to 100 ppm or more of HCFC-123 for 4 wk produced nonfatal liver damage in guinea pigs, namely hepatic fatty changes predominantly in the portal area (zone I) without increases in AST, ALT and ICDH. The NOAEL of HCFC-123 for four wk in guinea pigs may be 30 ppm. Peroxisome proliferation, which may result in hepatocellular tumor induction, was not observed in guinea pigs exposed to HCFC-123.
